Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2017-06-30 Regulatory Filings
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 95% confidence The document is a press release dated June 30, 2017, announcing a co-promotion agreement between Ipsen and Saol Therapeutics for the drug Dysport®. It details the terms, context, and includes extensive Important Safety Information (ISI) and Indications for both Dysport® and Lioresal® Intrathecal. This content—a strategic business announcement combined with detailed product safety/indication information—is characteristic of a general corporate announcement or press release, rather than a formal regulatory filing like a 10-K, an Earnings Release (ER), or a specific financial report (IR, AR). Since it is a formal announcement of a business development, and it doesn't fit the specific categories like M&A (TAR), Capital Change (CAP), or Director Dealing (DIRS), the most appropriate general category for a significant, non-standard corporate announcement that is not a financial report is Regulatory Filings (RNS), which serves as a broad category for official company news releases that don't fit elsewhere, or potentially a Legal/Contractual filing if viewed through that lens, but RNS is the best fit for a press release of this nature.
2017-06-30 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated June 30, 2017, announcing a co-promotion agreement between Ipsen and Saol Therapeutics for the drug Dysport® in the US. The content focuses on a business development/commercial partnership, product indications, and safety information. This type of announcement, detailing strategic business arrangements and commercial activities, fits best under the category of general corporate news or regulatory filings that are not specifically financial reports (10-K, IR, ER) or management changes (MANG). Since it is a specific announcement about a commercial agreement rather than a general regulatory filing (RNS) or a specific financial report, and it doesn't fit other categories like CAP (financing), TAR (M&A), or DIV, it is most appropriately classified as a general Regulatory Filing (RNS) as a catch-all for significant corporate news that isn't covered by the more specific codes, or potentially a general announcement (RPA if it were announcing the publication of a report, which it is not). Given the nature of a press release detailing a commercial partnership, RNS (Regulatory Filings / General Regulatory Announcements) is the most suitable fallback category when a more specific business development code is absent. It is not an Earnings Release (ER), Interim Report (IR), or a Capital/Financing Update (CAP).
2017-06-30 French
Share buybacks / Liquidity contracts Description of share buyback program
Transaction in Own Shares Classification · 98% confidence The document explicitly details 'Disclosure of transactions in own shares between 19/06/2017 and 23/06/2017'. It provides a table listing the volume and price of shares acquired on specific dates by the issuer (IPSEN). This content directly corresponds to the definition of a report detailing the company buying back or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS). The document length is short (2300 chars), but it is the report itself, not an announcement of a report, as it contains the detailed transaction data.
2017-06-27 English
Rachat d'actions / Contrat de liquidité Descriptif du programme de rachat
Transaction in Own Shares Classification · 99% confidence The document text explicitly contains the heading "Déclaration des transactions sur actions propres réalisées du 19/06/2017 au 23/06/2017" (Declaration of transactions in own shares carried out from 06/19/2017 to 06/23/2017). This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The provided table shows aggregated daily transaction data (volume and weighted average price) for the issuer IPSEN. This matches the filing type code POS.
2017-06-27 French
Rachat d'actions / Contrat de liquidité Descriptif du programme de rachat
Transaction in Own Shares Classification · 99% confidence The document text is titled 'Déclaration des transactions sur actions propres réalisées du 12/06/2017 au 16/06/2017' (Declaration of transactions on own shares carried out from 12/06/2017 to 16/06/2017). It contains a table detailing daily transactions (volume, weighted average price) for the issuer IPSEN over a specific period. This content directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The filing type code is POS.
2017-06-21 French
Share buybacks / Liquidity contracts Description of share buyback program
Transaction in Own Shares Classification · 98% confidence The document explicitly details 'Disclosure of transactions in own shares between 12/06/2017 and 16/06/2017' and presents aggregated data showing the 'Daily total volume (in number of shares)' and 'Daily weighted average price of shares acquired' for transactions involving the issuer's stock. This content directly corresponds to the definition of a report detailing the company buying back or selling its own shares. This matches the 'Transaction in Own Shares' category (POS).
2017-06-21 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.